Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Point72 Asset Management, L.P. ownership in VRTX / Vertex Pharmaceuticals Incorporated

On February 14, 2024 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 0 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $0 USD as of December 31, 2023. The entity filed a previous 13F-HR on November 14, 2023 disclosing 85,414 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 16,600 of underlying shares valued at $7,412,564 USD and put options representing 3,600 of underlying shares valued at $1,607,544 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -85,414 -100.00 0 -100.00
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 85,414 -161,025 -65.34 29,702 -65.75 0.0867
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 246,439 -12,061 -4.67 86,724 6.48 0.2579
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 258,500 147,661 133.22 81,446 154.45 0.2522
2023-05-15 2022-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 110,839 3,439 3.20 32,008 2.93 0.1088
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 110,839 3,439 32,008 0.1088
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 107,400 107,400 31,097 0.1242
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -47,600 -100.00 0 -100.00
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 47,600 47,600 10,453 0.0417
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -66,500 -100.00 0 -100.00
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 66,500 -597,473 -89.98 13,408 -90.60 0.0602
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 663,973 440,873 197.61 142,681 170.60 0.6666
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 223,100 92,900 71.35 52,727 48.82 0.2572
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 130,200 130,200 35,430 0.1814
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -114,821 -100.00 0 -100.00
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 114,821 -80,490 -41.21 25,140 -24.03 0.1322
2019-11-15 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 195,311 77,939 66.40 33,090 53.74 0.2032
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 117,372 6,654 6.01 21,524 5.68 0.1126
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 110,718 42,518 62.34 20,367 80.22 0.0924
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 68,200 -34,700 -33.72 11,301 -43.02 0.0552
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 102,900 -241,915 -70.16 19,833 -66.16 0.0818
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 344,815 314,815 1,049.38 58,605 1,098.71 0.2339
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 30,000 -679,817 -95.77 4,889 -95.40 0.0204
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 709,817 -199,413 -21.93 106,373 -23.05 0.4592
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 909,230 898,089 8,061.12 138,239 9,526.67 0.6170
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,141 -260,522 -95.90 1,436 -95.17 0.0081
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 271,663 -615,337 -69.37 29,706 -54.54 0.1656
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 887,000 887,000 0.00 65,345 0.4569
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -838,700 -100.00 0 -100.00
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 838,700 838,700 0.00 66,668 0.5114
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -15,000 -100.00 0 -100.00
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,000 15,000 0.00 1,562 0.0123
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -29,200 -100.00 0 -100.00
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 29,200 12,700 76.97 3,445 75.77 0.0235
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 16,500 -426,800 -96.28 1,960 -96.06 0.0138
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 443,300 -491,400 -52.57 49,787 -43.74 0.3747
2014-08-14 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 934,700 934,700 88,497 0.5673
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 16,600 -20.95 7,413 -22.14 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 21,000 9,521 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM Put 3,600 -49.30 1,608 -50.06 n/a n/a n/a
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM Put 7,100 3,219 n/a n/a n/a
2025-07-21 2025-03-31 13F/A VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 20,000 8,054 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.